chartexchange

GMAB
Genmab A/S ADS
stockNASDAQADR

At CloseNov 18, 2026 3:59:59 PM EST
50.97USD-1.896%(-0.99)2,956,729
Pre-marketNov 18, 2026 9:29:30 AM EST
51.48USD-0.924%(-0.48)
After-hoursNov 18, 2026 4:35:30 PM EST
51.42USD+0.872%(+0.44)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Copenhagen, Koebenhavn V, Denmark
Previous Close
$51.96
Beta
0.91
52-Week High
$59.97 2026-10-28
52-Week Low
$23.62 2026-06-03
SMA 50
$41.88
SMA 200
$31.73
Avg. Vol 10D
4.38M
Avg. Vol 30D
5.48M
Avg. Vol 90D
3.64M
Relative Vol
0.54
616.59M
589.06M
0.4100%
1,800,000
150,000
GMAB Profile

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund.

GMAB Performance
PeriodPriceDateChangeBeta
1W53.872026-11-11-5.37%-1.888
1M38.502026-10-19+32.40%1.059
3M32.962026-08-18+54.66%1.098
6M26.372026-05-18+93.31%0.646
1Y30.322025-11-18+68.12%0.905
2Y20.672024-11-18+146.61%—
5Y42.362021-11-18+20.34%0.706
GMAB Stock Summary

Genmab A/S ADS (NASDAQ:GMAB) stock price today is $50.98, and today's volume is 2,957,022. GMAB is down 1.896% today. The 30 day average volume is 5.48M. GMAB market cap is $31.43B with 616.59M shares outstanding.